Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 2/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.41 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.41 |
| ▸ | TACR3 | P29371 | 7/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL28621807 | 1.00 | BBOX1 (0.41) | BBOX1EGLN1FTOTACR3SMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL28621808 | 1.00 | BBOX1 (0.41) | BBOX1EGLN1FTOTACR3SMN1; SMN2 | |
| SCHEMBL22345591 | 0.91 | BBOX1 (0.44) | BBOX1EGLN1FTOTACR3SMN1; SMN2 | |
| SCHEMBL22345593 | 0.91 | BBOX1 (0.44) | BBOX1EGLN1FTOTACR3SMN1; SMN2 | |
| Iodide SCHEMBL22345354 | 0.90 | BBOX1 (0.43) | BBOX1EGLN1FTOTACR3SMN1; SMN2 | |
| Iodide SCHEMBL22345583 | 0.90 | BBOX1 (0.43) | BBOX1EGLN1FTOTACR3SMN1; SMN2 | |
| Iodide SCHEMBL22345356 | 0.90 | BBOX1 (0.43) | BBOX1EGLN1FTOTACR3SMN1; SMN2 | |
| SCHEMBL28621806 | 0.84 | CNR2 (0.38) | TACR3SMN1; SMN2KMT2AMEN1KDM4E | |
| Iodide SCHEMBL28632522 | 0.79 | ALDH1A1 (0.42) | TACR3KMT2AMEN1KDM4E | |
| Iodide SCHEMBL29564118 | 0.79 | ALDH1A1 (0.42) | TACR3KMT2AMEN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220132847-A1 | CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH | SYNGENTA CROP PROTECTION AG (CH) | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220132847-A1 | CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH | NOTUM, DDT, CYP51A1 | BBOX1 28/4885EGLN1 300/4885FTO 2614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.